|
Volumn 5, Issue 4, 2014, Pages 445-451
|
Heterocycle-fused lupane triterpenoids inhibit Leishmania donovani amastigotes
|
Author keywords
[No Author keywords available]
|
Indexed keywords
1' H LUP 20(29) ENO[2,3 B]PYRIDIN 28 OIC ACID;
1' H LUP 20(29) ENO[3,2 C]PYRAZOL 28 OIC ACID;
1' H LUPA 2,20(29) DIENO[3,2 B]INDOL 28 OIC ACID;
2 (HYDROXYMETHYLENE) 3 OXOLUP 20(29) EN 28 OIC ACID;
2 HYDROXYMETHYLENE;
20(29) DIHYDROLUP 2 EN[2,3 D]ISOXAZOL 28 OIC ACID;
28 HYDROXYLUPA 2,20(29) DIENO[2,3 D]ISOXAZOLE;
28 O ACETYL TRITERPENE;
28 OXIMINOLUPA 2,20(29) DIEN[2,3 B]PYRAZINE;
28 OXOLUPA 2,20(29) DIENO[2,3 B]PYRAZINE;
28 OXOLUPA 2,20(29) DIENO[2,3 D]ISOXAZOLE;
3 OXIMINOLUP 20(29) EN 28 OIC ACID;
3BETA (3 CARBOXY 3 METHYLBUTANOYLOXY)LUP 20(29) EN 28 OIC ACID;
4 AZA 3 OXOHOMOLUP 20(29) EN 28 OIC ACID;
BETULIC ACID;
BETULIN;
BETULONIC ACID;
BETULONIC ALDEHYDE;
HETEROCYCLIC COMPOUND;
INDOLE DERIVATIVE;
ISOXAZOLE DERIVATIVE;
LUPA 2,20(29) DIENO[2,3 B]PYRAZIN 28 OIC ACID;
LUPA 2,20(29) DIENO[2,3 D]ISOXAZOL 28 OIC ACID;
LUPA 2,20(29) DIENO[2,3 D]PYRAZIN 28 AMIDE;
PYRAZINE DERIVATIVE;
PYRAZOLE DERIVATIVE;
PYRIDINE DERIVATIVE;
TRITERPENOID;
UNCLASSIFIED DRUG;
AMASTIGOTE;
ARTICLE;
BIOLOGICAL ACTIVITY;
CONCENTRATION (PARAMETERS);
CONTROLLED STUDY;
CYTOTOXICITY;
DRUG ACTIVITY;
DRUG SELECTIVITY;
DRUG STRUCTURE;
HUMAN;
HUMAN CELL;
IC 50;
LEISHMANIA DONOVANI;
MACROPHAGE;
NONHUMAN;
PRIORITY JOURNAL;
STRUCTURE ACTIVITY RELATION;
STRUCTURE ANALYSIS;
|
EID: 84896906313
PISSN: 20402503
EISSN: 20402511
Source Type: Journal
DOI: 10.1039/c3md00282a Document Type: Article |
Times cited : (54)
|
References (26)
|